Mo1826 ONE-YEAR CLINICAL OUTCOMES OF SWITCHING TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON MAINTENANCE OF INTRAVENOUS INFLIXIMAB THERAPY WITH OR WITHOUT REMISSION: A MULTI-CENTER COHORT STUDY
June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Yoo Jin Lee, Kyeong Ok Kim, Eun Soo Kim, Hyeong Ho Jo, Seung Wook Hong, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Eun Young Kim, Sung Wook Hwang